Anti-emetic activity of ghrelin in ferrets exposed to the cytotoxic anti-cancer agent cisplatin.
about
Nausea: a review of pathophysiology and therapeuticsTreatment of Breakthrough and Refractory Chemotherapy-Induced Nausea and VomitingFood restriction, refeeding, and gastric fill fail to affect emesis in musk shrews.Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover studyGhrelin and motilin receptor agonists: time to introduce bias into drug design.The use of olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy.The hungry stomach: physiology, disease, and drug development opportunities.A Dunnione Compound MB12662 Improves Cisplatin-Induced Tissue Injury and EmesisGhrelin prevents cisplatin-induced mechanical hyperalgesia and cachexia.Ghrelin, the peripheral hunger hormone.Development of drugs for gastrointestinal motor disorders: translating science to clinical need.Cisplatin-induced emesis: systematic review and meta-analysis of the ferret model and the effects of 5-HT₃ receptor antagonistsGhrelin receptor modulators and their therapeutic potential.Ghrelin signaling in the gut, its physiological properties, and therapeutic potential.Olanzapine for chemotherapy-induced nausea and vomiting: a systematic review.Therapeutic applications of ghrelin agonists in the treatment of gastroparesis.Ghrelin and motilin receptors as drug targets for gastrointestinal disorders.The safety of antiemetic medications for the prevention of chemotherapy-induced nausea and vomiting.Management of Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients.Is there a need to identify new anti-emetic drugs?Ghrelin and Motilin Control Systems in GI Physiology and Therapeutics.Chemotherapy-induced pica and anorexia are reduced by common hepatic branch vagotomy in the rat.Rikkunshito for Preventing Chemotherapy-Induced Nausea and Vomiting in Lung Cancer Patients: Results from 2 Prospective, Randomized Phase 2 Trials.Neurokinin-1 receptor blocker CP-99 994 improved emesis induced by cisplatin via regulating the activity of gastric distention responsive neurons in the dorsal motor nucleus of vagus and enhancing gastric motility in rats.Expression of the ghrelin receptor gene in neurons of the medulla oblongata of the rat.Visually induced nausea causes characteristic changes in cerebral, autonomic and endocrine function in humans.Ghrelin selectively reduces mechanosensitivity of upper gastrointestinal vagal afferents.Anti-emetic Action of the Brain-Penetrating New Ghrelin Agonist, HM01, Alone and in Combination With the 5-HT Antagonist, Palonosetron and With the NK Antagonist, Netupitant, Against Cisplatin- and Motion-Induced Emesis in (House Musk Shrew)
P2860
Q26771877-FDFC0367-D454-4DE6-9E28-8AF325E12CCDQ26784070-530548DA-67E4-4D0C-BDC1-3C54FC6F25AAQ30433586-BBE194F7-C246-414D-BA7A-D09925BFE233Q34009312-E8C0016D-8A1F-4D9F-8CD0-640C83BA4A57Q34398651-8B1D5771-1B76-46AF-B6FA-4ADF33CC9AD2Q34647257-E116BED4-0548-4EDD-B49A-5D4C6603C8A7Q35215647-CC467486-00EF-4770-8CF1-E88C0A295EEFQ36015715-FAE343C9-537E-4A28-9C37-6CB151DDBDB3Q36415811-76BAAC8C-D960-4196-A0F8-A47BEEA34803Q36799392-99DC7311-4647-4403-A25D-B484E9AA1055Q37079261-CA60B5A6-2242-4CBD-BF52-3FD814AE2292Q37761329-F8E63846-D10B-4780-A997-A0917447B5A9Q37855871-39C0FBFA-1A96-463F-B3B5-5EDCDCB01FD9Q38126139-CEF8C6A5-7188-4317-902D-FDE116D4D3FAQ38187578-255CE4D0-422F-4E38-AAB0-CFABDE6BE37CQ38363587-F95BC696-85A7-466F-B44F-50B3D6B8F61BQ38590705-E862C655-7C91-4DC0-A543-8E44222A767CQ38677762-B081F25E-FE4E-4BFC-8810-FC3296F33D8CQ39266110-B99C64A1-FC67-4F7E-A3E0-95C336EB97AFQ39341803-503BE21D-D436-45D5-875C-58570BF1EA1BQ43358150-A6C64A03-D7D4-4AAE-BE89-7D047747881CQ46815780-7F686918-E934-48BC-AA28-25AA53300C90Q47641840-37D9CC04-BC86-423D-B2A9-47A9BDC6DDE5Q48062468-AE3D591A-0796-4C64-BC0A-1878DF342C64Q48195049-6ED86062-999C-4A29-9574-0A22E94B5C44Q48391867-1E88534B-8209-4217-AFE7-E1B93A0C8A88Q55043153-E26AA796-E1E1-4F20-817F-07933D19E440Q58799118-CC4EF052-6059-486B-A523-788EB6876BC3
P2860
Anti-emetic activity of ghrelin in ferrets exposed to the cytotoxic anti-cancer agent cisplatin.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Anti-emetic activity of ghreli ...... c anti-cancer agent cisplatin.
@ast
Anti-emetic activity of ghreli ...... c anti-cancer agent cisplatin.
@en
type
label
Anti-emetic activity of ghreli ...... c anti-cancer agent cisplatin.
@ast
Anti-emetic activity of ghreli ...... c anti-cancer agent cisplatin.
@en
prefLabel
Anti-emetic activity of ghreli ...... c anti-cancer agent cisplatin.
@ast
Anti-emetic activity of ghreli ...... c anti-cancer agent cisplatin.
@en
P2093
P50
P1433
P1476
Anti-emetic activity of ghreli ...... ic anti-cancer agent cisplatin
@en
P2093
Andrew G King
Jason Witherington
Man P Ngan
P356
10.1016/J.NEULET.2005.08.062
P407
P577
2005-09-22T00:00:00Z